Drug
Fluciclovine F-18 clinical trials
Also written Axumin, FACBC and GE-148 (18F).
- studies test it
- 36
- open now
- 9
- in phase 3
- 3
- first study started
- 2003
Keep track of what changes. Save the fluciclovine F-18 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
36 studies that test it; most in 2019 (6)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 8
- Phase 1
- 5
- Phase 2
- 14
- Phase 3
- 3
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 31
Emory University (5) · Blue Earth Diagnostics (4) · David M. Schuster, MD (4) · Baptist Health South Florida (3) · University of Utah (2) · Children's Hospital of Philadelphia (2) · OHSU Knight Cancer Institute (1) · Tulane University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses fluciclovine F-18 is read from its arms, and is right about nine times in ten.
Testing it · 36
- 18F-Fluciclovine PET/CT in Multiple MyelomaRecruitingPhase 2National Cancer Institute (NCI)NCT06103838Written as 18F-fluciclovine injection
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceRecruitingPhase 4Blue Earth DiagnosticsNCT07569926Written as fluciclovine (18F)
- Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGGRecruitingEarly Phase 1Children's Hospital of PhiladelphiaNCT05555550Written as 18F-Fluciclovine
- Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of GlioblastomaRecruitingEarly Phase 1Abramson Cancer Center at Penn MedicineNCT06613841Written as Fluciclovine F18
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic RadiosurgeryRecruitingPhase 1Baptist Health South FloridaNCT06048094Written as 18F fluciclovine
- Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic RadiosurgeryRecruitingPhase 1Baptist Health South FloridaNCT04689048Written as 18F fluciclovine
- 18F-Fluciclovine PET-MRI in High-grade GliomaRecruitingEarly Phase 1Children's Hospital of PhiladelphiaNCT05553041Written as 18F-Fluciclovine PET-MRI
- Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain MetastasisRecruitingPhase 2Baptist Health South FloridaNCT05554302Written as 18F-Fluciclovine
- Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CTRecruitingPhase 1Brigham and Women's HospitalNCT06062745Written as 18F-fluciclovine
- Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer OutcomesActive, not recruitingPhase 2Emory UniversityNCT03762759Written as Fluciclovine F18
- Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETActive, not recruitingPhase 4OHSU Knight Cancer InstituteNCT05722925Written as Fluciclovine PET/CT
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging TherapiesCompletedPhase 2Tulane UniversityNCT04158245Written as 18F-fluciclovine PET Scan
- Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain MetastasesCompletedPhase 3Blue Earth DiagnosticsNCT04410133Written as 18F fluciclovine
- Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)CompletedPhase 2Blue Earth DiagnosticsNCT04410367Written as 18F fluciclovine
- Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerCompletedPhase 1Emory UniversityNCT04750473Written as Fluciclovine F18
- An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate CancerTerminatedPhase 4M.D. Anderson Cancer CenterNCT04134208Written as Fluciclovine F18
- Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the BoneCompletedPhase 2University of UtahNCT03707184Written as Fluciclovine F18
- 18F-Fluciclovine PET/CT in the Assessment of Pancreatic TransplantsCompletedEarly Phase 1University of UtahNCT04852523Written as 18F-fluciclovine
- 18F-Fluciclovine PET and Multiparametric MR ImagingWithdrawnPhase 2Loma Linda UniversityNCT03925675Written as PET/CT with F-Fluciclovine (Axumin)
- FACBC Outcomes for Post ProstatectomyCompletedPhase 2/3Emory UniversityNCT01666808Written as FACBC
See all 36 studies that test fluciclovine F-18 →
Given in every arm · 1 — fluciclovine F-18 is usual care beside what is tested
Codes
What other systems call fluciclovine F-18 · ClinicalTrials.gg INT004135
- MeSH (NLM) C117460fluciclovine F-18Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 38R1Q0L1ZEFLUCICLOVINE F-18Confirmed FDA, NLM
- RxNorm 1796118One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C117460 | fluciclovine F-18 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 38R1Q0L1ZE | FLUCICLOVINE F-18 | Confirmed FDA, NLM |
| RxNorm | 1796118 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.